A Critical Evaluation of Bifidobacterial Adhesion to the Host Tissue
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Bifidobacteria are common inhabitants of the human gastrointestinal tract that, despite a long history of research, have not shown any pathogenic potential whatsoever. By contrast, some bifidobacteria are associated with a number of health-related benefits for the host. The reported beneficial effects of bifidobacteria include competitive exclusion of pathogens, alleviation of symptoms of irritable bowel syndrome and inflammatory bowel disease, and modulation of intestinal and systemic immune responses. Based on these effects, bifidobacteria are widely used as probiotics by pharmaceutical and dairy industries. In order to exert a beneficial effect bifidobacteria have to, at least transiently, colonize the host in a sufficient population size. Besides other criteria such as resistance to manufacturing processes and intestinal transit, potential probiotic bacteria are tested for adhesion to the host structures including intestinal epithelial cells, mucus, and extracellular matrix components. In the present review article, we summarize the current knowledge on bifidobacterial structures that mediate adhesion to host tissue and compare these to similar structures of pathogenic bacteria. This reveals that most of the adhesive structures and mechanisms involved in adhesion of bifidobacteria to host tissue are similar or even identical to those employed by pathogens to cause disease. It is thus reasonable to assume that these structures and mechanisms are equally important for commensal or probiotic bacteria and play a similar role in the beneficial effects exerted by bifidobacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 1×
“Of note, a very recent study links bifidobacteria in the gut microbiota to enhanced anti-tumor immune responses and support of checkpoint-inhibition cancer therapy using a monoclonal antibody (Sivan et al., 2015).”
BackgroundDynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.004 · Cited by 3,315 · cited 1×
“During the first period of life when newborns are exclusively breast-fed, members of the genus Bifidobacterium are one of the predominant bacterial groups of the microbiota in the lower GIT (Yatsunenko et al., 2012; Bäckhed et al., 2015; Walker et al., 2015).”
BackgroundThe gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564 · cited 2×
“…of bifidobacteria in the GIT including improvement of symptoms of irritable bowel syndrome, inflammatory bowel disease and infectious diarrhea, modulation of intestinal and systemic immune responses, and resistance against colonization by pathogens (Gareau et al., 2010; Buffie and Pamer, 2013).”
BackgroundProbiotics and the gut microbiota in intestinal health and disease
Gareau, M. G., Sherman, P. M., & Walker, W. A. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.117 · Cited by 907
Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum
Del Re, B., Sgorbati, B., Miglioli, M., & Palenzona, D. (2000) · Letters in Applied Microbiology · doi:10.1046/j.1365-2672.2000.00845.x · Cited by 731
O'Connell Motherway, M., Zomer, A., Leahy, S. C., Reunanen, J., Bottacini, F., Claesson, M. J., O'Brien, F., Flynn, K., Casey, P. G., Moreno Munoz, J. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105380108 · Cited by 376
Implication of an Outer Surface Lipoprotein in Adhesion of Bifidobacterium bifidum to Caco-2 Cells
Guglielmetti, S., Tamagnini, I., Mora, D., Minuzzo, M., Scarafoni, A., Arioli, S., Hellman, J., Karp, M., & Parini, C. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00124-08 · Cited by 128 · cited 4×
“One specific protein that has been suspected to play a role in adhesion of bifidobacteria to IECs is BopA, lipoprotein of the cell envelope specifically found in B. bifidum strains (Guglielmetti et al., 2008; Gleinser et al., 2012).”
BackgroundInfluentialSugar coating: bacterial protein glycosylation and host–microbe interactions
Tan, F. Y. Y., Tang, C. M., & Exley, R. M. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.03.016 · Cited by 103 · cited 1×
“…non-proteinaceous component of the bacterial envelope that have been associated with adhesion to host tissue of Gram positive pathogens are glycoconjugates including exopolysaccharides, lipoteichoic, and wall teichoic acids (Weidenmaier and Peschel, 2008; Tytgat and Lebeer, 2014; Tan et al., 2015).”
BackgroundStudy of the adhesion of bifidobacterium bifidum MIMBb75 to human intestinal cell lines
Guglielmetti, S., Tamagnini, I., Minuzzo, M., Arioli, S., Parini, C., Comelli, E., & Mora, D. (2009) · Current Microbiology · doi:10.1007/s00284-009-9415-x · Cited by 56
Cited by
Benefaction of probiotics for human health: A review
George Kerry, R., Patra, J. K., Gouda, S., Park, Y., Shin, H.-S., & Das, G. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.01.002 · Cited by 898
Immunomodulatory Effects of Probiotics on Cytokine Profiles
Azad, M. A. K., Sarker, M., & Wan, D. (2018) · BioMed Research International · doi:10.1155/2018/8063647 · Cited by 521
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey
Han, S., Lu, Y., Xie, J., Fei, Y., Zheng, G., Wang, Z., Liu, J., Lv, L., Ling, Z., Berglund, B., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.609722 · Cited by 481
Journey of the Probiotic Bacteria: Survival of the Fittest
Mendonça, A. A., Pinto-Neto, W. D. P., da Paixão, G. A., Santos, D. D. S., De Morais, M. A., & De Souza, R. B. (2022) · Microorganisms · doi:10.3390/microorganisms11010095 · Cited by 82
Metadata
- Authors
- Westermann, C., Gleinser, M., Corr, S. C., & Riedel, C. U.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2016-08-05
- Volume
- 7
- Pages
- 1220-1220
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2477632416
- Cited by
- 77
- References
- 10
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.